You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lyso-thermosensitive liposomal doxorubicin

Showing 51 - 75 of 1,636
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leiomyosarcoma Trial in Los Angeles (Lurbinectedin, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Los Angeles, California
    Sarcoma Oncology Center
Oct 16, 2023

Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous Trial in Brasilia (Miltefosine 50mg, Pentoxifylline 400mg, Liposomal

Recruiting
  • Leishmaniasis; Brazilian
  • Leishmaniasis, Mucocutaneous
  • Miltefosine 50mg
  • +2 more
  • Brasilia, DF, Brazil
    Hospital Universitario de Brasilia
Sep 13, 2023

Ovarian Cancer Trial (EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), )

Terminated
  • Ovarian Cancer
  • (no location specified)
Sep 24, 2021

Breast Cancer Trial in Wuhan (Camrelizumab, Liposomal Doxorubicin, Losartan)

Not yet recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College of HUST
Oct 27, 2021

Diffuse Large Cell Lymphoma, Burkitt's Lymphoma, High Grade B-cell Lymphoma Trial in United States (Rituximab, IT Cytarabine)

Completed
  • Diffuse Large Cell Lymphoma
  • +2 more
  • Buffalo, New York
  • +4 more
Oct 29, 2021

Breast Reduction Trial in Rochester (Bupivacaine Hydrochloride, Liposomal Bupivacaine)

Not yet recruiting
  • Breast Reduction
  • Bupivacaine Hydrochloride
  • Liposomal Bupivacaine
  • Rochester, Minnesota
    Mayo Clinic Minnesota
May 26, 2023

Spine Fusion, Anesthesia, Local Trial (Liposomal bupivacaine, Bupivacaine)

Not yet recruiting
  • Spine Fusion
  • Anesthesia, Local
  • (no location specified)
Oct 25, 2023

Fabry Disease Trial in United Kingdom, United States (ST-920)

Recruiting
  • Fabry Disease
  • ST-920
  • Irvine, California
  • +20 more
Feb 1, 2023

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Phoenix, Arizona
  • +2 more
Jun 27, 2022

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)

Not yet recruiting
  • Hepatocellular Carcinoma Non-resectable
  • BioPearl™
  • Brussels, Belgium
  • +5 more
Jun 20, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

Recruiting
  • Ovarian Cancer
  • +3 more
  • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
  • Blacktown, New South Wales, Australia
  • +5 more
Nov 9, 2022

Ovarian Cancer Trial in United States (AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD))

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +15 more
Feb 16, 2022

Metastatic Colorectal Cancer Trial in Madison (Liposomal irinotecan, TAS102, Bevacizumab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Liposomal irinotecan
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
May 2, 2023

Quality of Recovery From Mastectomy With and Without PECS Blocks

Not yet recruiting
  • Post Operative Pain
  • Quality of Recovery After Mastectomy
  • Mastectomy with PECS blocks
  • Liposomal bupivacaine
  • (no location specified)
Mar 20, 2023

Ovarian Cancer Trial in Worldwide (Bevacizumab, liposomal doxorubicin, paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • Bruxelles, Belgium
  • +116 more
May 5, 2022

Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Dec 29, 2022

Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

Not yet recruiting
  • Breast Cancer Stage 2 and 3
  • (no location specified)
Nov 24, 2023

Bariatric Surgery Candidate, Post-operative Pain Trial in Richmond (Treatment with liposomal bupivacaine, Treatment with

Recruiting
  • Bariatric Surgery Candidate
  • Post-operative Pain
  • Treatment with liposomal bupivacaine
  • Treatment with standard bupivacaine
  • Richmond, Virginia
    Virginia Commonwealth University
Oct 12, 2023

Bioavailability of Vitamin D Trial in Gdansk (Liposomal Vitamin D, Traditional Vitamin D)

Completed
  • Bioavailability of Vitamin D
  • Liposomal Vitamin D
  • Traditional Vitamin D
  • Gdańsk, Poland
    Gdański Uniwersytet Medyczny
Aug 24, 2023

Hepatocellular Carcinoma Trial in Worldwide (ThermoDox, Dummy infusion)

Completed
  • Hepatocellular Carcinoma
  • Los Angeles, California
  • +60 more
Oct 23, 2018

Lower Extremity Revascularization Trial in Eau Claire (Bupivacaine liposome, Placebo)

Not yet recruiting
  • Lower Extremity Revascularization
  • Bupivacaine liposome
  • Placebo
  • Eau Claire, Wisconsin
    Mayo Clinic Health System - Eau Claire
Aug 7, 2023

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023